The American Cancer Society (ACS) and Pfizer have inked a three-year, $15 million initiative to mitigate cancer care disparities.
Called "Change the Odds: Uniting to Improve Cancer Outcomes," the project is intended to serve "medically underrepresented communities across the U.S. by enhancing awareness of and access to cancer screenings [particularly for breast and prostate cancer], clinical trial opportunities, and patient support and comprehensive navigation," the ACS and Pfizer said.
